Trials / Conditions / Microsatellite Stable

Microsatellite Stable

9 registered clinical trials studyying Microsatellite Stable — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatell NCT07500298	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectab NCT05572684	NextCure, Inc.	Phase 1 / Phase 2
Withdrawn	Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer NCT05730673	CytoDyn, Inc.	Phase 2
Withdrawn	Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer NCT04119830	Roswell Park Cancer Institute	Phase 2
Unknown	Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer NCT05160727	Zhejiang Cancer Hospital	Phase 2
Unknown	Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate NCT04262687	Federation Francophone de Cancerologie Digestive	Phase 2
Unknown	Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer NCT04194359	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2
Active Not Recruiting	Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer NCT03983993	Emory University	Phase 2
Completed	Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer NCT03396926	University of California, San Francisco	Phase 2